End of Life Alert: Per Bayer's published EOL notices, MEDRAD® Stellant CT and Spectris Solaris EP MR reach end of life 12/31/2028; Mark V ProVis is past its 12/31/2025 date. SEVA continues to supply compatible disposables. Learn more →
Compatibility Matrix

Find your injector. Confirm the fit.

SEVA supports syringe-based contrast injection systems across the major CT, MR, and angiographic OEM platforms. We tell you plainly where we fit and where we don't. No guessing. No surprises at the injector head.

4
OEM platforms covered across CT, MR, and Angio
20+
Injector models validated for SEVA syringe compatibility
Plain
We list where we don't fit, not just where we do
Full Compatibility Matrix

Every platform. Every answer.

The contrast injector market consolidates around five OEM platforms. SEVA supports four of them: Bayer, Bracco, Guerbet, and Nemoto. The matrix shows exactly where we fit and where we don't. Select a manufacturer tab to see the full list for that platform.

Modality Injector OEM Status SEVA Support
CT Stellant Classic EOL 12/31/2028 Service, parts, and consumables discontinued after 12/31/2028. SEVA supply continues. Supported
CT MCT / MCT Plus / Vistron CT / Envision CT Legacy Bayer CT platforms. SEVA supply continues. Supported
CT Stellant FLEX Current generation. Active Bayer support. Not Supported
CT Centargo Current generation. Active Bayer support. Not Supported
MR Spectris Solaris MR Past 12/31/2025 Bayer service ended. Not the EP variant. Supported
MR Spectris Solaris EP MR EOL 12/31/2028 Includes EP Mobile. SEVA supply continues. Supported
MR Spectris (non-Solaris) Legacy MR platform. Order only if legacy units remain in service. Supported
MR MRXperion Current generation. Active Bayer support. Not Supported
Angio Mark V ProVis Past 12/31/2025 Bayer service ended. SEVA supply continues. Supported
Angio Mark 7 Arterion Current generation. Active Bayer support. Not Supported
Modality Injector OEM Status SEVA Support
CT Empower CTA®+ Active platform. Standard Bracco support. Supported
CT Empower CT (legacy) Legacy generation. Confirm with SEVA for specific model. Supported
CT CT Exprès™ Current generation. Active Bracco support. Not Supported
MR EmpowerMR® Active platform. Standard Bracco support. Supported
MR MAX 3™ Current generation. Active Bracco support. Not Supported
Modality Injector OEM Status SEVA Support
CT OptiVantage® DH Active platform. Standard Guerbet support. Supported
CT OptiVantage® SH Single-head variant. Confirm with SEVA for volume compatibility. Supported
MR OptiStar® LE / Elite Active platform. Standard Guerbet support. Supported
Angio Illumena® Active platform. Standard Guerbet support. Supported
Modality Injector OEM Status SEVA Support
CT CT Motion™ Active platform. Growing installed base. Not Supported
MR MAX 3™ Current generation. Syringeless MR system. Not Supported
Modality Injector OEM Status SEVA Support
CT Dual Shot CT (Alpha / GX) Active platform. Standard Nemoto support. Supported
CT Dual Shot NEXT Current generation. Active Nemoto support. Not Supported
Angio Rempress Active platform. Standard Nemoto support. Supported
Compatibility information is provided for reference and reflects SEVA's current validated product portfolio. Contact SEVA before ordering to confirm compatibility for your specific injector model and configuration. SEVA Devices is not affiliated with, sponsored by, or endorsed by any OEM manufacturer. All injector trademarks are the property of their respective owners.
Where SEVA Fits

Syringe-based, single-patient. That's our lane.

  • Single-use CT contrast syringesDrop-in replacements for the leading syringe-based CT injector platforms.
  • Single-use MR contrast syringesPower injection-rated, MR-safe, validated for major MR injector platforms.
  • Angiography injection kitsComplete kits for angiography platforms including EOL-affected Mark V ProVis.
  • Patient-side tubing and extension setsFor CT, MR, and Angio circuits. Saline syringes for dual-channel platforms.
  • EOL platform continuityDedicated supply for the four platforms in Bayer's published end-of-life transition: Stellant Classic, Spectris Solaris MR, Spectris Solaris EP MR, and Mark V ProVis.
Where We Don't

We tell you plainly where we can't help.

  • Proprietary closed-system injectorsCertain current-generation platforms use proprietary syringe systems SEVA does not currently support.
  • Multi-patient contrast platformsSEVA's current product line is single-patient only. Multi-patient solutions are not currently available.
  • Injector hardware, service, or partsSEVA supplies disposables only. We do not supply injector hardware, service contracts, preventative maintenance, or calibration.
  • Contrast mediaSEVA does not supply contrast agents. Disposables are sold separately from and compatible with all major contrast media brands.
Bayer EOL Context

Bayer is leaving. SEVA is staying.

Bayer has end-of-lifed four contrast injector product lines. Two are already past their cutoff. Two more follow on 12/31/2028. SEVA supplies compatible disposables for the equipment your department already owns, with no forced capital event and no bundling.

Replacement injectors run $20,000 to $50,000 per unit, come with new proprietary disposables, new training requirements, and indefinite single-vendor pricing. The clinical performance is largely unchanged.

MEDRAD® Mark V ProVis
Past · 12/31/2025
SEVA support: Injection kits and tubing for Mark V ProVis continue. Supply uninterrupted past Bayer's EOL date.
MEDRAD® Spectris Solaris MR
Past · 12/31/2025
SEVA support: MR syringes for Spectris Solaris MR continue. Note: this EOL does not apply to the Spectris Solaris EP MR variant.
MEDRAD® Stellant Classic CT
EOL · 12/31/2028
SEVA support: CT syringes for Stellant Classic remain available and will continue past the 12/31/2028 OEM cutoff.
MEDRAD® Spectris Solaris EP MR
EOL · 12/31/2028
SEVA support: MR syringes for Spectris Solaris EP MR (including EP Mobile) continue past the 12/31/2028 OEM cutoff.
Sample Evaluation Process

From first contact to confirmed fit.

Most SEVA evaluations move from inquiry to sample delivery in under two weeks. Here is what to expect.

Step 01

Tell us your platform

Share your injector model and approximate annual contrast-enhanced procedure volume. SEVA confirms compatibility within one business day and opens the conversation — that is all it takes to get started. To price accurately, SEVA then gathers a few specifics, like your installed base and preferred purchasing channel.

Step 02

Receive a quote

With your specifics in hand, your quote follows quickly — per-unit pricing on the disposables, built around your volume. No bundling, no contrast media requirement, no proprietary lock-in.

Step 03

Evaluate samples

SEVA ships evaluation samples for hands-on trial by your technologists. Sample turnaround typically within days. VAC support materials arrive with the samples.

Step 04

VAC and contracting

SEVA supports your Value Analysis Committee review with a complete documentation kit: 510(k) clearances, ISO 13485, side-by-side specs, and cost comparison worksheets.

Request Information

Not sure if SEVA fits your injector? Ask us directly.

Tell us what you run. We will confirm compatibility, send a quote, and get samples to you on a schedule that works for your evaluation timeline.